Literature DB >> 7195926

The effect of copper supplementation on the brindled mouse: a clinico-pathological study.

H Nagara, K Yajima, K Suzuki.   

Abstract

Brindled mottled is a neurological mutant mouse. Hemizygous males have many clinical and biochemical features in common with kinky hair syndrome (KHS) in humans, and usually die around postnatal day 15, after severe emaciation. Neuronal mitochondrial abnormalities and neuronal degeneration in the cerebrum and cerebellum were constant neuropathological findings in this mutant. A single intraperitoneal injection of cupric chloride, 10 micrograms/g body weight, resulted in an improvement of clinical symptoms and prevention of neuronal degeneration. The degree of improvement was dependent on the date of injection, and day 7 to 10 postnatal appeared to the most effective date. The male hemizygotes which received cupric chloride injections at day 7 or 10 overcame the lethality, and no neuronal degeneration was detected in these mice, although neuronal mitochondrial changes were still persistent. However, following two injections at days 7 and 10, no abnormalities were detected in the cerebral cortical neurons. Even at the ultrastructural level, abnormal mitochondria were very scarce. In the cerebellum, however, mitochondrial changes in the Purkinje cells, particularly in the rostral portion, and generation of white matter were noted in these mice, which were clinically perfectly healthy, judging from the growth rate and behavior. However, cerebellar changes were far less in those which received additional injections later on. These observations indicate that, at least in brindled mutant mice, supplementation of copper is quite beneficial for clinical improvement and the prevention of neuropathological lesions, but the date of administration appears to have crucial importance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7195926     DOI: 10.1097/00005072-198107000-00006

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  10 in total

Review 1.  Peptidylgycine α-amidating monooxygenase and copper: a gene-nutrient interaction critical to nervous system function.

Authors:  Danielle Bousquet-Moore; Richard E Mains; Betty A Eipper
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

2.  Golgi study on macular mutant mouse after copper therapy.

Authors:  H Kawasaki; T Yamano; S Iwane; M Shimada
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Cerebellar changes of the female mice heterozygous for brindled gene.

Authors:  T Yamano; K Suzuki
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

4.  ATP7A gene addition to the choroid plexus results in long-term rescue of the lethal copper transport defect in a Menkes disease mouse model.

Authors:  Anthony Donsante; Ling Yi; Patricia M Zerfas; Lauren R Brinster; Patricia Sullivan; David S Goldstein; Joseph Prohaska; Jose A Centeno; Elisabeth Rushing; Stephen G Kaler
Journal:  Mol Ther       Date:  2011-08-30       Impact factor: 11.454

5.  Neuropathologic study in the heterozygotes of X-linked brindled mutant mouse.

Authors:  H Matsushima; A Okuno; Y Eto; K Maekawa
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

6.  Hepatic metallothionein synthesis in neonatal Mottled-Brindled mutant mice.

Authors:  J E Piletz; H R Herschman
Journal:  Biochem Genet       Date:  1983-06       Impact factor: 1.890

Review 7.  Mutations in humans and animals which affect copper metabolism.

Authors:  J Camakaris; M Phillips; D M Danks; R Brown; T Stevenson
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

8.  Brindled mottled mouse: morphological changes of brain and visceral organs in hemizygous males following copper supplementation.

Authors:  K Suzuki; H Nagara
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

9.  The effect of copper supplementation on the concentration of copper in the brain of the brindled mouse.

Authors:  G Wenk; K Suzuki
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

10.  Cerebrospinal Fluid-Directed rAAV9-rsATP7A Plus Subcutaneous Copper Histidinate Advance Survival and Outcomes in a Menkes Disease Mouse Model.

Authors:  Marie Reine Haddad; Eun-Young Choi; Patricia M Zerfas; Ling Yi; Diego Martinelli; Patricia Sullivan; David S Goldstein; Jose A Centeno; Lauren R Brinster; Martina Ralle; Stephen G Kaler
Journal:  Mol Ther Methods Clin Dev       Date:  2018-07-09       Impact factor: 6.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.